Update: Expanded Recall of Other-Sonic Generic Ultrasound Transmission Gel
June 15, 2012 | Strategic Insights for Ambulatory Care
Preview
The U.S. Food and Drug Administration (FDA) has updated its safety information regarding the recall of Other-Sonic Generic Ultrasound Transmission Gel. Originally, FDA advised clinicians to stop using several lots of the product because of concerns that the products were contaminated with bacteria that may have caused patients to develop eye infections (see the May 4, 2012, Physician Practice E-News). FDA’s update expands the recall to include four additional lots manufactured between June and December 2011. Healthcare providers should not use Other-Sonic Generic Ultrasound Transmission Gel from lot numbers 060111 through 120111.